Detalles de la búsqueda
1.
Peritoneal mesometrial resection with lymphadenectomy following prior hysterectomy in intermediate/high-risk endometrial cancer: feasibility and safety.
Arch Gynecol Obstet
; 309(4): 1569-1574, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38217762
2.
Treatment and survival of patients with malignant ovarian sex cord-stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database.
J Surg Oncol
; 128(1): 111-118, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36975108
3.
Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1).
Int J Gynecol Cancer
; 33(2): 223-230, 2023 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36631151
4.
Hysterectomy in benign conditions: a 20-year single-center retrospective on the development of surgical techniques.
Arch Gynecol Obstet
; 307(3): 807-812, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36301346
5.
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
N Engl J Med
; 381(25): 2416-2428, 2019 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31851799
6.
Single-center study for robotic-assisted laparoscopic sacropexies: a one-fits-all strategy for pelvic organ prolapse?
Arch Gynecol Obstet
; 306(6): 2009-2015, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35974180
7.
The effect of fertility-sparing surgery on sexuality and global quality of life in women with malignant ovarian germ cell and sex cord stromal tumors: an analysis of the CORSETT database of the AGO study group.
Arch Gynecol Obstet
; 304(6): 1541-1549, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34287678
8.
A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancer.
Gynecol Oncol
; 156(1): 23-31, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31791552
9.
Extracellular vesicle-associated miRNAs in ovarian cancer - design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistance.
Clin Chem Lab Med
; 57(7): 1053-1062, 2019 06 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30422797
10.
Prognostic significance of PD-1 and PD-L1 positive tumor-infiltrating immune cells in ovarian carcinoma.
Int J Gynecol Cancer
; 29(9): 1389-1395, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31492714
11.
ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer.
Gynecol Oncol
; 150(2): 355-360, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29807696
12.
Intraoperative navigation in robotically assisted compartmental surgery of uterine cancer by visualisation of embryologically derived lymphatic networks with indocyanine-green (ICG).
J Surg Oncol
; 113(5): 554-9, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26792025
13.
Embryologically based radical hysterectomy as peritoneal mesometrial resection (PMMR) with pelvic and para-aortic lymphadenectomy for loco-regional tumor control in endometrial cancer: first evidence for efficacy.
Arch Gynecol Obstet
; 294(1): 153-60, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26596725
14.
[(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results.
Eur J Nucl Med Mol Imaging
; 42(1): 56-65, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25223420
15.
ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance.
Clin Chem
; 60(10): 1282-9, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25015375
16.
Sentinel Lymph node detection in endometrial cancer - Anatomical and scientific facts.
Best Pract Res Clin Obstet Gynaecol
; 94: 102483, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38401483
17.
Definition of compartment-based radical surgery in uterine cancer: modified radical hysterectomy in intermediate/high-risk endometrial cancer using peritoneal mesometrial resection (PMMR) by M Höckel translated to robotic surgery.
World J Surg Oncol
; 11: 198, 2013 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23947937
18.
Definition of compartment-based radical surgery in uterine cancer: radical hysterectomy in cervical cancer as 'total mesometrial resection (TMMR)' by M Höckel translated to robotic surgery (rTMMR).
World J Surg Oncol
; 11: 211, 2013 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-23972128
19.
Tumor cell cytoplasmic metallothionein expression associates with differential tumor immunogenicity and prognostic outcome in high-grade serous ovarian carcinoma.
Front Oncol
; 13: 1252700, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38023247
20.
Total mesometrial resection (TMMR) for cervical cancer FIGO IB-IIA: first results from the multicentric TMMR register study.
J Gynecol Oncol
; 33(1): e9, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34910390